Cargando…
Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study
OBJECTIVES: We aimed to assess the level of prior SARS-CoV-2 infection in socially deprived neighbourhoods after the first wave of the pandemic, and to identify factors associated with seropositivity. DESIGN: A cross-sectional study. SETTING: Three socially deprived neighbourhoods of the city of Per...
Autores principales: | Beaumont, Adeline, Durand, Cécile, Ledrans, Martine, Schwoebel, Valérie, Noel, Harold, Le Strat, Yann, Diulius, Donatien, Colombain, Léa, Médus, Marie, Gueudet, Philippe, Mouly, Damien, Aumaître, Hugues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611237/ https://www.ncbi.nlm.nih.gov/pubmed/34815286 http://dx.doi.org/10.1136/bmjopen-2021-053201 |
Ejemplares similares
-
Séroprévalence des anticorps anti-SARS-CoV-2 après la première vague épidémique au sein d’une population vulnérable
por: Beaumont, A., et al.
Publicado: (2021) -
Seroprevalence of Asian Lineage Chikungunya Virus Infection on Saint Martin Island, 7 Months after the 2013 Emergence
por: Gay, Noellie, et al.
Publicado: (2016) -
Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study
por: Outh, Roderau, et al.
Publicado: (2021) -
Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997–2014 Longitudinal Study in Paris, France
por: Guigue, Nicolas, et al.
Publicado: (2018) -
Corrigendum: Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997–2014 Longitudinal Study in Paris, France
por: Guigue, Nicolas, et al.
Publicado: (2018)